456 related articles for article (PubMed ID: 16303136)
1. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?
Abedini A; Raleigh DP
J Mol Biol; 2006 Jan; 355(2):274-81. PubMed ID: 16303136
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
Kapurniotu A; Schmauder A; Tenidis K
J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
[TBL] [Abstract][Full Text] [Related]
4. Effects of sequential proline substitutions on amyloid formation by human amylin20-29.
Moriarty DF; Raleigh DP
Biochemistry; 1999 Feb; 38(6):1811-8. PubMed ID: 10026261
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
Jaikaran ET; Nilsson MR; Clark A
Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
[TBL] [Abstract][Full Text] [Related]
6. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.
Tenidis K; Waldner M; Bernhagen J; Fischle W; Bergmann M; Weber M; Merkle ML; Voelter W; Brunner H; Kapurniotu A
J Mol Biol; 2000 Jan; 295(4):1055-71. PubMed ID: 10656810
[TBL] [Abstract][Full Text] [Related]
7. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
[TBL] [Abstract][Full Text] [Related]
8. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin.
Nilsson MR; Raleigh DP
J Mol Biol; 1999 Dec; 294(5):1375-85. PubMed ID: 10600392
[TBL] [Abstract][Full Text] [Related]
9. Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis.
Scrocchi LA; Chen Y; Waschuk S; Wang F; Cheung S; Darabie AA; McLaurin J; Fraser PE
J Mol Biol; 2002 May; 318(3):697-706. PubMed ID: 12054816
[TBL] [Abstract][Full Text] [Related]
10. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives.
Pappalardo G; Milardi D; Magrì A; Attanasio F; Impellizzeri G; La Rosa C; Grasso D; Rizzarelli E
Chemistry; 2007; 13(36):10204-15. PubMed ID: 17902185
[TBL] [Abstract][Full Text] [Related]
11. Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes.
Jha S; Sellin D; Seidel R; Winter R
J Mol Biol; 2009 Jun; 389(5):907-20. PubMed ID: 19427320
[TBL] [Abstract][Full Text] [Related]
12. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.
Sellin D; Yan LM; Kapurniotu A; Winter R
Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100
[TBL] [Abstract][Full Text] [Related]
13. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
[TBL] [Abstract][Full Text] [Related]
14. Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin.
Wei L; Jiang P; Yau YH; Summer H; Shochat SG; Mu Y; Pervushin K
Biochemistry; 2009 Mar; 48(11):2368-76. PubMed ID: 19146426
[TBL] [Abstract][Full Text] [Related]
15. Comparing the structural properties of human and rat islet amyloid polypeptide by MD computer simulations.
Andrews MN; Winter R
Biophys Chem; 2011 Jun; 156(1):43-50. PubMed ID: 21266296
[TBL] [Abstract][Full Text] [Related]
16. The role of His-18 in amyloid formation by human islet amyloid polypeptide.
Abedini A; Raleigh DP
Biochemistry; 2005 Dec; 44(49):16284-91. PubMed ID: 16331989
[TBL] [Abstract][Full Text] [Related]
17. The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils.
Sabaté R; Espargaró A; de Groot NS; Valle-Delgado JJ; Fernàndez-Busquets X; Ventura S
J Mol Biol; 2010 Nov; 404(2):337-52. PubMed ID: 20887731
[TBL] [Abstract][Full Text] [Related]
18. Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy.
Soong R; Brender JR; Macdonald PM; Ramamoorthy A
J Am Chem Soc; 2009 May; 131(20):7079-85. PubMed ID: 19405534
[TBL] [Abstract][Full Text] [Related]
19. Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers.
Liang G; Zhao J; Yu X; Zheng J
Biochemistry; 2013 Feb; 52(6):1089-100. PubMed ID: 23331123
[TBL] [Abstract][Full Text] [Related]
20. Structure and thermodynamics of amylin dimer studied by Hamiltonian-temperature replica exchange molecular dynamics simulations.
Laghaei R; Mousseau N; Wei G
J Phys Chem B; 2011 Mar; 115(12):3146-54. PubMed ID: 21384830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]